Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 5—May 2021

SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USA

Hanna Y. Ehrlich, Adora Harizaj, Lauren Campbell, McKenzie Colt, Karen Yuan, Therese Rabatsky-Ehr, Daniel M. Weinberger, Vivian Leung, Linda M. Niccolai, and Sunil ParikhComments to Author 
Author affiliations: Yale University, New Haven, Connecticut, USA (H.Y. Ehrlich, L. Campbell, M. Colt, K. Yuan, D.M. Weinberger, L.M. Niccolai, S. Parikh); Connecticut Department of Public Health, Hartford, Connecticut, USA (A. Harizaj, T. Rabatsky-Ehr, V. Leung)

Main Article

Table 1

Summary of point prevalence survey results of severe acute respiratory syndrome coronavirus 2 infection in 34 nursing homes, Connecticut, USA*

Category Residents
No. follow-up PPS Positive test results from PPSs† No. symptomatic at PPS testing No. cases detected between PPSs† No. symptomatic at time of non-PPS testing No. PPS Positive test results from staff PPSs
Total 198 44 11 93 70 205 87
Average (SD) 6.0 (2.3) 1.3 (1.5) 0.6 (0.9) 2.7 (7.6) 4.1 (9.1) 6.2 (2.0) 2.6 (4.9)

*Results of the first PPS in residents in (6); results displayed here are those of subsequent surveys only. In brief, 601 cases were detected in the first PPS (average 16.8, SD 13.5). One additional facility, coronavirus disease naive at the time of the initial PPS and therefore not included in the original study, detected 0 cases in its first PPS. PPS, point prevalence survey.
†Excludes residents transferred into facilities with known coronavirus infection.

Main Article

Page created: April 01, 2021
Page updated: April 20, 2021
Page reviewed: April 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.